Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Daniel L. Menichella
Age : 60
Public asset : 86,000 USD
Linked companies : Kaleido Biosciences, Inc.
Summary 
Presently, Daniel L. Menichella is President, Chief Executive Officer & Director at Kaleido Biosciences, Inc. Mr. Menichella is also on the board of Spybiotech Ltd.

Mr. Menichella previously was Vice President-Business Development for Merck KGaA, Chief Business Officer of Zyngenia, Inc., Senior Vice President for MorphoSys AG, Chief Business Officer & Vice President at Applied Genetic Technologies Corp., Chief Executive Officer at CureVac AG, Senior Vice President-Business Development for Grifols Therapeutics, Inc., Senior Vice President-Business Development of Talecris Biotherapeutics Holdings Corp. and Chief Business Officer for Bamboo Therapeutics, Inc.

He received an undergraduate degree from Harvard University and an MBA from The University of North Carolina at Charlotte.


Current positions of Daniel L. Menichella 
NameTitle Since
Kaleido Biosciences, Inc.
(Biotechnology & Medical Research)
President, Chief Executive Officer & Director 2020
Spybiotech Ltd. Director -


Holdings of Daniel L. Menichella 
NameEquities%Valuation
Kaleido Biosciences, Inc. (KLDO)
(Biotechnology & Medical Research)
20,0000.047%86,000 USD


Daniel L. Menichella: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
11/17HENRIK FISKER : Fisker unveils electric SUVs to beat Tesla over driving range
RE
11/16ELON MUSK : Tesla's Musk sells another 934,000 shares to pay taxes after exercising options - filing
RE
11/15WARREN BUFFETT : Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company
RE
11/16TED ROGERS : Rogers names Staffieri interim CEO as chair stamps authority after family feud
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
11/15ELON MUSK : Tesla's Musk sells $930 mln in shares to cover stock option tax - filings
RE
11/15ELON MUSK : Tesla's shares extend selloff after Musk tweets
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
More news


© 2021 People and Ownership :   
Daniel L. Menichella : Connections